✦ LIBER ✦

Cyclosporine treatment of advanced interstitial pneumonitis associated with systemic sclerosis

✍ Scribed by Murashima, Atsuko ;Sekigawa, Iwao ;Takasaki, Yoshinari ;Hashimoto, Hiroshi

Publisher: Informa UK (Informa Healthcare)
Year: 1999
Tongue: English
Weight: 533 KB
Volume: 9
Category: Article
ISSN: 0169-1163
DOI: 10.1007/bf03041264

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Very low-dose cyclosporin treatment of s

Very low-dose cyclosporin treatment of steroid-resistant interstitial pneumonitis associated with Sjögren's syndrome

✍ H. Ogasawara; M. Sekiya; A. Murashima; T. Hishikawa; Y. Tokano; N. Sekigawa; N. 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 457 KB

Rituximab in the treatment of systemic s

Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo

✍ Dimitrios Daoussis; Andrew P. Andonopoulos 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 117 KB

Systemic sclerosis–related pulmonary hyp

Systemic sclerosis–related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies

✍ Jérôme Le Pavec; Reda E. Girgis; Noah Lechtzin; Stephen C. Mathai; David Launay; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

Bronchoalveolar lavage cellular profiles

Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis–associated interstitial lung disease are not predictive of disease progression

✍ Nicole S. L. Goh; Srihari Veeraraghavan; Sujal R. Desai; Derek Cramer; David M. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## Abstract ## Objective To evaluate the prognostic value of bronchoalveolar lavage (BAL) cellular profiles in patients with systemic sclerosis–associated interstitial lung disease (SSc‐ILD). ## Methods BAL cellularity was examined in relation to mortality (n = 141), serial pulmonary function fi

A one-year, phase I/IIa, open-label pilo

A one-year, phase I/IIa, open-label pilot trial of imatinib mesylate in the treatment of systemic sclerosis–associated active interstitial lung disease

✍ Dinesh Khanna; Rajeev Saggar; Maureen D. Mayes; Fereidoun Abtin; Philip J. Cleme 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

Association of hepatocyte growth factor

Association of hepatocyte growth factor promoter polymorphism with severity of interstitial lung disease in Japanese patients with systemic sclerosis

✍ Kana Hoshino; Takashi Satoh; Yasushi Kawaguchi; Masataka Kuwana 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 2 views